Genetic Testing: Types, Benefits and Limitations for Personalized Healthcare and Family Planning

Sara Huston^*
*Correspondence: Sara Huston, Department of Genome Sciences, University of Duke, North Carolina, USA, Email:

Keywords

Genome • Healthcare • Genetic Testing

Introduction

There are several types of genetic testing that can be performed depending on the specific goals of the test. This type of testing is used to diagnose a specific genetic disorder when symptoms are already present. Diagnostic testing is usually recommended for individuals who have a family history of a genetic disorder or who are showing symptoms of a genetic disorder. This type of testing is used to determine an individual's risk of developing a genetic disorder later in life. Predictive testing is usually recommended for individuals who have a family history of a genetic disorder but do not have any symptoms [1].

Literature Review

This type of testing is used to determine if an individual is a carrier of a genetic disorder. Carrier testing is usually recommended for individuals who are planning to have children and want to know if they are at risk of passing on a genetic disorder to their children. This type of testing is used to detect genetic disorders in a developing fetus. Prenatal testing is usually recommended for pregnant women who have a family history of a genetic disorder or who are at high risk of having a child with a genetic disorder. This type of testing is used to screen newborns for certain genetic disorders that can be treated early in life. Newborn screening is usually done using a blood sample taken from the baby's heel.

Discussion

Genetic testing can provide several benefits to individuals and families. Genetic testing can help diagnose genetic disorders early, which can lead to earlier treatment and better outcomes. Genetic testing can help determine an individual's risk of developing a genetic disorder, which can inform medical decision-making and lifestyle choices. Genetic testing can help couples make informed decisions about having children and can inform reproductive options such as in vitro fertilization or adoption. Genetic testing can help identify genetic mutations that can be targeted by specific medications or treatments, leading to more personalized and effective treatments [2].

While genetic testing can provide many benefits, there are also some limitations to the technology. Genetic testing can sometimes produce false positive or false negative results, which can lead to unnecessary medical procedures or missed diagnoses. Not all genetic tests are available to everyone, and some tests may only be available in certain regions or for certain populations. Genetic testing can sometimes produce results that are difficult to interpret or that have uncertain clinical significance, leading to anxiety or confusion for patients and healthcare providers. Genetic testing can reveal sensitive information about an individual's health, which can raise concerns about privacy and discrimination [3,4].

Genetic testing also raises several ethical and legal issues that must be considered. Patients undergoing genetic testing must provide informed consent, which means they must be fully informed about the risks and benefits of the test and must be given the opportunity to ask questions and make informed decisions. Genetic testing can reveal information that could be used to discriminate against individuals in employment, insurance, or Genetic testing is the process of analyzing an individual's DNA to identify variations, mutations, or changes in their genetic code. It is a powerful tool that can provide valuable information about an individual's health, including the risk of developing certain diseases, the effectiveness of certain medications, and the possibility of passing on certain genetic conditions to offspring. In this article, we will discuss genetic testing, its types, benefits, and limitations. This type of testing is used to confirm or rule out a suspected genetic condition. It involves analyzing a person's DNA to identify a specific gene or mutation that is responsible for the condition [5].

Predictive testing is used to determine an individual's risk of developing a specific genetic condition, such as breast cancer or Huntington's disease. This type of testing is often recommended for individuals with a family history of a genetic condition. Carrier testing is used to determine whether an individual carries a gene for a specific genetic condition. This type of testing is often recommended for individuals who are planning to have children. Prenatal testing is performed during pregnancy to determine whether a fetus has a genetic condition. This type of testing can be done through amniocentesis or chorionic villus sampling. Newborn screening is a type of genetic testing that is performed shortly after a baby is born to identify certain genetic conditions that may not be apparent at birth. Genetic testing can help detect the risk of developing certain diseases at an early stage, which can allow for early intervention and treatment [6].

Conclusion

Genetic testing can help healthcare providers determine the most effective medications and dosages for an individual based on their genetic makeup. Genetic testing can help individuals make informed decisions about family planning, including whether to have children, and if so, what the risk of passing on a genetic condition is. For individuals with a family history of a genetic condition, genetic testing can provide peace of mind or early warning, allowing them to take proactive steps to manage their health.

Acknowledgement

None.

Conflict of Interest

There are no conflicts of interest by author.

References

1. Siravegna, Giulia, Benedetta Mussolin, Michela Buscarino and Giorgio Corti, et al. "Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients." Nat Med 21 (2015): 795-801.

Google Scholar, Crossref, Indexed at

2. Göring, Harald HH, Joanne E. Curran, Matthew P. Johnson and Thomas D. Dyer, et al. "Discovery of expression QTLs using large-scale transcriptional profiling in human lymphocytes." Nat Genet 39 (2007): 1208-1216.

Google Scholar, Crossref, Indexed at

3. West, Marilyn AL, Kyunga Kim, Daniel J. Kliebenstein and Hans Van Leeuwen, et al. "Global eQTL mapping reveals the complex genetic architecture of transcript-level variation in Arabidopsis." Genetics 175 (2007): 1441-1450.

Google Scholar, Crossref, Indexed at

4. Zore, Temeka, Lindsay L. Kroener, Chunmin Wang and Lian Liu, et al. “Transfer of embryos with segmental mosaicism is associated with a significant reduction in live-birth rate.” Fertil Steril 111 (2019): 69-76.

Google Scholar, Crossref, Indexed at

5. Hou, Wenhui, Yan Xu, Rong Li and Junli Song, et al. “Role of aneuploidy screening in preimplantation genetic testing for monogenic diseases in young women.” Fertil Steril 111 (2019): 928-935.

Google Scholar, Crossref, Indexed at

6. Macklon, S., J. Geraedts and B. Fauser. “Conception to ongoing pregnancy: The ‘black box’ of early pregnancy loss.” Hum Reprod Update 8 (2002): 333–343.

Google Scholar, Crossref, Indexed at